Home › Therapeutic areas › Immunology › Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (15 companies)

Companies with an active program in Systemic Lupus Erythematosus.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ACET Adicet Bio ImmunologyNeurology+2 Rare 1 Phase 1 $26.0M 8
ALLO Allogene Therapeutics ImmunologyOncology Rare 1 Phase 2 $256M 10
ALMS Alumis DermatologyImmunology+1 2 Phase 3 $628M 5
AUTL Autolus Therapeutics HematologyImmunology+3 Rare 1 Approved $290M 12
CABA Cabaletta Bio DermatologyImmunology+2 Rare 1 Phase 2 $220M 8
IPSC Century Therapeutics ImmunologyMetabolic+1 Rare 2 Phase 1 $249M 9
CLYM Climb Bio HematologyImmunology+1 Rare 2 Phase 2 $574M 8
CGEM Cullinan Therapeutics HematologyImmunology+2 Rare 2 NDA Submitted $602M 10
FATE Fate Therapeutics ImmunologyOncology+1 Rare 1 Phase 2 $124M 10
INAB IN8bio ImmunologyOncology 1 Phase 1 $8.9M 4
KYMR Kymera Therapeutics DermatologyImmunology+1 Rare 1 Phase 2 $10.4B 5
NKTR Nektar Therapeutics DermatologyImmunology+2 1 Phase 3 $1.23B 11
NKTX Nkarta ImmunologyNeurology+1 Rare 1 Phase 1 $89.6M 8
XNCR Xencor ImmunologyNeurology+1 Rare 1 Approved $2.59B 28
ZBIO Zenas BioPharma DermatologyImmunology+2 Rare 1 NDA Submitted $1.88B 11